# Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis

> **NCT00287573** · PHASE2,PHASE3 · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 488 (actual)

## Conditions studied

- Coronary Restenosis

## Interventions

- **DEVICE:** TAXUS Express2
- **PROCEDURE:** Brachytherapy (beta source)

## Key facts

- **NCT ID:** NCT00287573
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2004-12
- **Final completion:** 2010-01
- **Target enrollment:** 488 (ACTUAL)
- **Last updated:** 2010-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00287573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00287573, "Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00287573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*